
AUSTIN, Texas, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnology ...

RA’ANANA, Israel and NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. ...

AstraZeneca today announced positive results from the Phase III FALCON trial comparing Faslodex 500mg ...
Click to continue to site. Closing